LWM
DXCM icon

Laidlaw Wealth Management’s DexCom DXCM Stock Holding History

Laidlaw Wealth Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,664
Closed -$213K – 382
2022
Q1 		$213K Sell
1,664
-324
-16% -$35.4K 0.04% 363
2021
Q4 		$267K Buy
+1,988
New +$286K 0.04% 328

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Laidlaw Wealth Management's DXCM Position: Q2 2022 in Review

Laidlaw Wealth Management sold out of DexCom (DXCM) in Q2 2022, closing a stake of 1,664 shares — an estimated $213K sold.

Laidlaw Wealth Management first reported a position in DXCM in Q4 2021 and held it in 2 quarters. The position peaked at $267K in Q4 2021. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Laidlaw Wealth Management reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Laidlaw Wealth Management sold 1,664 DexCom shares in Q2 2022, an estimated $213K.
  • Laidlaw Wealth Management first reported a position in DexCom in Q4 2021 and held it in 2 quarters.
  • Laidlaw Wealth Management's DexCom position peaked at $267K in Q4 2021.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Laidlaw Wealth Management's 13F filing for Q2 2022, filed 12 Aug 2022.